{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:15:50Z","timestamp":1775974550287,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:00:00Z","timestamp":1537574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The aims of the current study were: (i) to examine the prescribing of preventative medication in a cohort of people with advanced lung cancer on hospital admission and discharge across different healthcare systems; and (ii) to explore the factors that influence preventative medication prescribing at hospital discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study was conducted across two centres in the UK and the US. The prescribing of preventative medication was examined at hospital admission and discharge for patients who died of lung cancer. A zero\u2010inflated negative binomial regression model was used to examine the association between preventative medications at discharge and patient\u2010 and hospital\u2010based factors. The classes of preventative medication prescribed included were: vitamins and minerals, and antidiabetic, antihypertensive, antihyperlipidaemic and antiplatelet medications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the UK site (<jats:italic>n<\/jats:italic> = 125), the mean number of preventative medications prescribed was 1.9 [standard deviation (SD) 1.7) on admission, and 1.7 (SD 1.7) on discharge, and in the US site (<jats:italic>n<\/jats:italic> = 191) the mean was 2.6 (SD 2.2) on admission and 1.9 (SD 2.2) on discharge. The model found a significant association between the number of preventative drugs prescribed on admission and the number on discharge; it also found a significant association between the total number of drugs prescribed on discharge and the number of preventative medications on discharge. Other indicators related to patient and hospital factors were not significantly associated with the number of preventative medications supplied on discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The use of preventative medication was common in lung cancer patients, despite undergoing discharge. Patient\u2010 and hospital\u2010based factors did not influence the prescribing of preventative medication.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.13735","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T05:01:24Z","timestamp":1536210084000},"page":"2802-2810","source":"Crossref","is-referenced-by-count":19,"title":["Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life \u2013 an international cohort study"],"prefix":"10.1111","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1496-9341","authenticated-orcid":false,"given":"Adam","family":"Todd","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Medical Sciences Newcastle University  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaafar","family":"Al\u2010Khafaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Nevada, Reno School of Medicine  Reno NV USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasima","family":"Akhter","sequence":"additional","affiliation":[{"name":"Wolfson Research Institute for Health and Wellbeing Durham University  Durham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adetayo","family":"Kasim","sequence":"additional","affiliation":[{"name":"Wolfson Research Institute for Health and Wellbeing Durham University  Durham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Quibell","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine Royal Victoria Infirmary  Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Merriman","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center  Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly M.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Division of Geriatric and Palliative Medicine The University of Texas Health Science Center at Houston  Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,22]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"Wordwide data.World Cancer Research Fund International [online]. Available athttp:\/\/www.wcrf.org\/int\/cancer\u2010facts\u2010figures\/worldwide\u2010data(last accessed 29 July 2018)."},{"key":"e_1_2_10_3_1","unstructured":"Lung cancer estimated incidence mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. World Health Organization [online]. Available athttp:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx?cancer=lung(last accessed 29 July 2018)."},{"key":"e_1_2_10_4_1","unstructured":"Key statistics for lung cancer. American Cancer Society [online]. Available athttps:\/\/www.cancer.org\/cancer\/non\u2010small\u2010cell\u2010lung\u2010cancer\/about\/key\u2010statistics.html(last accessed 29 July 2018)."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(98)00039-7"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-012-9731-2"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00080-7"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2015-000941"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-014-9932-y"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2014.241"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.2816"},{"key":"e_1_2_10_12_1","unstructured":"Hospice care in the UK 2016. Hospice UK [online]. Available athttps:\/\/wwwhospiceukorg\/docs\/default\u2010source\/What\u2010We\u2010Offer\/publications\u2010documents\u2010and\u2010files\/hospice\u2010care\u2010in\u2010the\u2010uk\u20102016pdf?sfvrsn=0(last accessed 29 July 2018)."},{"key":"e_1_2_10_13_1","unstructured":"Facts and figures. Hospice care in America. National Hospice and Palliative Care Organization [online]. Available athttps:\/\/www.nhpco.org\/sites\/default\/files\/public\/Statistics_Research\/2017_Facts_Figures.pdf(last accessed 29 July 2018)"},{"key":"e_1_2_10_14_1","unstructured":"Quick facts. The University of Texas MD Anderson Cancer Centre [online]. Available athttps:\/\/www.mdanderson.org\/documents\/about\u2010md\u2010anderson\/about\u2010us\/facts\u2010and\u2010history\/quick\u2010facts.pdf(last accessed 29 July 2018)."},{"key":"e_1_2_10_15_1","unstructured":"Trust profile. The Newcastle upon Tyne Hospitals Foundation Trust [online]. Available at:http:\/\/www.newcastle\u2010hospitals.org.uk\/about\u2010us\/trust\u2010profile.aspx(last accessed 29 July 2018)."},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01124.x"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000880"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2012.0158"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2390-1"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2004.432"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199207000-00006"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12732"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0324"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2017.01.004"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-016-0086-7"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12975"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0289"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0327-0"},{"key":"e_1_2_10_30_1","unstructured":"KutnerMH NachtsheimCJ NeterJ.Applied Linear Regression Models 4th edn. McGraw\u2010Hill\/ Irwin 2004. Chicago. ISBN-10: 0073014664."}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.13735","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T16:25:16Z","timestamp":1694795116000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,22]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1111\/bcp.13735"],"URL":"https:\/\/doi.org\/10.1111\/bcp.13735","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,22]]}}}